{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:05:44Z","timestamp":1790996744553,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.parkreldis.2006.10.006","type":"journal-article","created":{"date-parts":[[2007,2,3]],"date-time":"2007-02-03T07:53:21Z","timestamp":1170489201000},"page":"224-229","source":"Crossref","is-referenced-by-count":36,"title":["Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"13","author":[{"given":"M.","family":"Bialecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Klodowska-Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Honczarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gawro\u0144ska-Szklarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Opala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Safranow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dro\u017adzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2006.10.006_bib1","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib2","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/hmg\/11.22.2787","article-title":"Functional association of the parkin gene promoter with idiopathic Parkinson's disease","volume":"11","author":"West","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.62.3.357","article-title":"The second gene for early onset Parkinson disease","volume":"62","author":"Bandmann","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0009-9236(95)90154-X","article-title":"Association between the oxidative polymorphism and early onset of Parkinson\u2019s disease","volume":"57","author":"Agundez","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib5","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.51.6.1587","article-title":"Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson\u2019s disease","volume":"51","author":"Agundez","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1212\/WNL.47.1.225","article-title":"CYP2D6 allelic frequencies in young-onset Parkinson\u2019s disease","volume":"47","author":"Sandy","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI200317575","article-title":"Rare genetic mutations shed light on the pathogenesis of Parkinson disease","volume":"111","author":"Dawson","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ana.10324","article-title":"A susceptibility gene for late-onset idiopathic Parkinson\u2019s disease","volume":"52","author":"Hicks","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/432588","article-title":"Identification of risk and age-onset genes on chromosome 1p in Parkinson disease","volume":"77","author":"Oliveira","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/WNL.56.3.375","article-title":"The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese","volume":"56","author":"Wu","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1531-8257(199903)14:2<219::AID-MDS1003>3.0.CO;2-9","article-title":"Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease","volume":"14","author":"Mellick","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/jnnp.67.4.518","article-title":"N-acetyltransferase-2 polymorphism in Parkinson's disease: the Rotterdam study","volume":"67","author":"Harhangi","year":"1999","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(99)00278-5","article-title":"Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism","volume":"266","author":"Bon","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression, and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0404.2004.00315.x","article-title":"The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphism on levodopa therapy in patients with sporadic Parkinson disease","volume":"110","author":"Bialecka","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00228-001-0415-4","article-title":"N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population","volume":"57","author":"Bialecka","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0009-9236(99)70076-7","article-title":"Relationship between acetylation polymorphism and risk of atopic diseases","volume":"65","author":"Gawronska-Szklarz","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib20","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/0140-6736(90)93163-J","article-title":"Detection of debrisoquine hydroxylation phenotypes","volume":"336","author":"Wolf","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib21","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/0140-6736(92)91196-F","article-title":"Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson disease","volume":"339","author":"Smith","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1212\/WNL.56.10.1363","article-title":"Parkinson\u2019s disease, CYP2D6 polymorphism, and age","volume":"56","author":"Payami","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000084302","article-title":"Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson\u2019s disease in a Polish population","volume":"53","author":"Bialecka","year":"2005","journal-title":"Eur Neurol"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ana.410330406","article-title":"Association of a monoamine oxidase B allele with Parkinson's disease","volume":"33","author":"Kurth","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.410370318","article-title":"An allelic association study of monoamine oxidase B in Parkinson's disease","volume":"37","author":"Ho","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1096-8628(19970418)74:2<154::AID-AJMG7>3.3.CO;2-A","article-title":"Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson's disease","volume":"74","author":"Costa","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib27","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1212\/WNL.58.9.1381","article-title":"MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD","volume":"58","author":"Hernan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mds.10624","article-title":"DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson\u2019s disease cases and unrelated controls","volume":"19","author":"Costa-Mallen","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2006.10.006_bib29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1212\/WNL.55.4.533","article-title":"Variability and validity of polymorphism association studies in Parkinson's disease","volume":"55","author":"Tan","year":"2000","journal-title":"Neurology"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802006002380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802006002380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T13:24:20Z","timestamp":1547040260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802006002380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S1353802006002380"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2006.10.006","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}